Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma

被引:0
|
作者
Wang, Li [1 ]
Zhang, Xin [2 ]
Lu, Yanrong [1 ]
Tian, Bole [1 ]
机构
[1] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
关键词
PREOPERATIVE CHEMORADIATION; MORBIDITY;
D O I
10.21037/gs-21-379
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:2340 / 2342
页数:3
相关论文
共 50 条
  • [1] Neoadjuvant therapy duration and outcome of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC).
    Shahda, Safi
    Perkins, Susan
    Cramer, Harvey M.
    House, Michael Garrett
    Nakeeb, Attila
    Zyromski, Nicholas J.
    Ceppa, Eugene P.
    Sehdev, Amikar
    Akisik, Fatih
    Lin, Jingmei
    Schmidt, Christian
    Ellsworth, Susannah G.
    O'Neil, Nina
    Link, Kristen
    O'Neil, Bert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [2] Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma
    Takaori, Ayaka
    Hashimoto, Daisuke
    Ikeura, Tsukasa
    Ito, Takashi
    Nakamaru, Koh
    Masuda, Masataka
    Nakayama, Shinji
    Yamaki, So
    Yamamoto, Tomohisa
    Fujimoto, Kosuke
    Matsuo, Yoshiyuki
    Akagawa, Shohei
    Ishida, Mitsuaki
    Yamaguchi, Kiyoshi
    Imoto, Seiya
    Hirota, Kiichi
    Uematsu, Satoshi
    Satoi, Sohei
    Sekimoto, Mitsugu
    Naganuma, Makoto
    [J]. PANCREATOLOGY, 2023, 23 (04) : 367 - 376
  • [3] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    [J]. DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461
  • [4] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
  • [5] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    [J]. Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
  • [6] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Homma, Yuki
    Taniguchi, Koichi
    Murakami, Takashi
    Nakagawa, Kazuya
    Nakazawa, Masatoshi
    Matsuyama, Ryusei
    Mori, Ryutaro
    Takeda, Kazuhisa
    Ueda, Michio
    Ichikawa, Yasushi
    Tanaka, Kuniya
    Endo, Itaru
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 670 - 676
  • [7] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Yuki Homma
    Koichi Taniguchi
    Takashi Murakami
    Kazuya Nakagawa
    Masatoshi Nakazawa
    Ryusei Matsuyama
    Ryutaro Mori
    Kazuhisa Takeda
    Michio Ueda
    Yasushi Ichikawa
    Kuniya Tanaka
    Itaru Endo
    [J]. Annals of Surgical Oncology, 2014, 21 : 670 - 676
  • [8] Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Eastburg, Benjamin
    Frisch, Austin
    Khan, Mariam
    Wright, Gerald P.
    Assifi, Mura
    Chandra, Sreenivasa
    Chung, Mathew
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S176 - S177
  • [9] Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Borhani, Amir A.
    Dewan, Rohit
    Furlan, Alessandro
    Seiser, Natalie
    Zureikat, Amer H.
    Singhi, Aatur D.
    Boone, Brian
    Bahary, Nathan
    Hogg, Melissa E.
    Lotze, Michael
    Zeh, Herbert J., III
    Tublin, Mitchell E.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (02) : 362 - 369
  • [10] Neoadjuvant Therapy for Achieving Margin Negative Resection in Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Chandrasekaran, S.
    Coveler, A. L.
    Chandrasekaran, S.
    Lucas, F. R.
    Patel, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S314 - S314